GHRS
GHRS
NASDAQ · Pharmaceuticals

Gh Research Plc

$18.61
+0.17 (+0.92%)
As of Nov 7, 10:09 PM ET ·
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 16 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +159.2% upside
Low Target $34.28
Average Target $48.23
High Target $66.93
Current Price $18.61
Current
$18.61
Target
$48.23
$34.28 $48.23 avg $66.93
Scenario Analysis
Bear Case
$34.28
84.2%
Low target
Base Case
$48.23
+159.2%
Avg target
Bull Case
$66.93
+259.6%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$31.44
-40.8% from high
52-Week Low
$12.04
+54.6% from low
Target vs 52W High
$48.23
+53.4% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 37 86% $1,330.33 -1.7%
RDY
Dr. Reddy's Laboratories
Sell 42 45% — +0.0%
JNJ
Johnson & Johnson
Buy 30 70% $299.55 +8.4%
MRK
Merck & Co. Inc.
Buy 35 71% $159.27 +8.5%
PFE
Pfizer Inc.
Hold 34 38% $33.90 +15.3%
BMY
Bristol-Myers Squibb Co
Hold 34 41% $174.50 +180.8%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 14 93% $36.26 -46.1%
ZTS
Zoetis Inc
Hold 22 41% $209.87 +164.3%